Budez Cr
Budesonide capsules for Crohn's disease and ulcerative colitis. It releases in the gut to act locally, so fewer side effects reach the rest of the body.
- Category
- Digestive Health
- Active ingredient
- Budesonide
- Route
- Oral use
- Form
- Capsule
- Strengths
- 3mg
Prescription and consultation requirements for Budez Cr vary by destination and are determined by the fulfilment partner.
Budez Cr details
- Conditions
- Crohn's Disease · Ulcerative Colitis
- Alternative names
- budesonide
- Therapeutic class
- Glucocorticoid
- Pharmacological class
- Corticosteroid
- Contraindications
- severe hepatic impairment; hypersensitivity to budesonide
- Minor side effects
- nausea; indigestion; headache
- Moderate side effects
- adrenal suppression; elevated glucose; facial oedema
- Serious side effects
- severe immunosuppression, requires immediate medical attention
- Dosage forms
- Capsule
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Sun Pharmaceutical Industries Ltd
- Onset Time
- 1–2 weeks
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Ketoconazole; Grapefruit
- Age restrictions
- Approved for adults and children over eight years.
Patient summary
Budesonide capsules for Crohn's disease and ulcerative colitis. It releases in the gut to act locally, so fewer side effects reach the rest of the body.
Mechanism of action
Releases budesonide directly in the ileum and ascending colon to suppress localised immune reactions and heal tissues.
Pregnancy and breastfeeding
Pregnancy: Use only if therapeutic benefit justifies risk. Breastfeeding: Consult a doctor.